Progressive Abduction Loading Therapy: A Phase IIb Stroke Rehabilitation Trial with Longitudinal Tracking
渐进性外展负荷疗法:纵向追踪的 IIb 期中风康复试验
基本信息
- 批准号:10011891
- 负责人:
- 金额:$ 48.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-06 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdjuvantAdmission activityAffectAnatomyApoptosisAttenuatedBehavioralBrain EdemaCaringChronicChronic PhaseClinical TrialsClinical assessmentsCorticospinal TractsCouplingDataDevelopmentElbowEnrollmentEquipmentExerciseFinancial compensationForce of GravityFutureGoalsHeightImpairmentIndividualInterventionIntervention StudiesInvestigationIschemic PenumbraJointsLesionMotorMotor NeuronsMotor PathwaysMovementNecrosisNeural PathwaysNeuronal PlasticityOutpatientsParticipantPathway interactionsPatientsPhasePhase III Clinical TrialsPopulationPractice GuidelinesProductionRandomized Clinical TrialsRecoveryRehabilitation therapyResidual stateScienceShoulderSignal TransductionStandardizationStrokeSurfaceTestingTranslationsUpper ExtremityWorkarmbasechronic strokecomparison groupcomparison interventioncritical perioddosageexperimental grouphapticshemiparesisimprovedischemic injurymotor impairmentneuroimagingnovelpre-clinicalpreclinical studypreventrecruitrelating to nervous systemresponserestorationstroke recoverystroke rehabilitationsynergismsystems researchvirtual
项目摘要
Project Summary
Preclinical rehabilitation studies in the chronic phase of upper extremity stroke recovery have demonstrated the
capacity to improve independent joint control in individuals with severe impairment, by reducing the expression
of abnormal shoulder abduction/elbow flexion coupling, or flexion synergy, following a science-based data-driven
intervention approach. Two decades of quantitative motor systems research underpins the concept of
systematically targeting independent joint control in this population. The leading hypothesis explaining stroke-
related loss of independent joint control is the increased reliance on contralesional corticoreticulospinal tract for
the production of movement in the affected arm. Partial restoration of independent joint control demonstrated in
preclinical studies logically extend this hypothesis by attributing improved movement to optimized use of residual
ipsilesional corticospinal tract likely originating in the ischemic penumbra. The anatomical circuit of residual
ipsilesional corticospinal tract is the only neural pathway available for the production of independent joint control,
or in functional terms, outward reaching against gravity. With neuroimaging studies of individuals with severe
chronic stroke supporting this hypothesis, it brings to light the supposition that optimized use of penumbral
corticospinal tract may be achieved early in recovery, specifically the critical period of neural plasticity, in
individuals with severe initial motor impairment. Stroke practice guidelines conclude that individuals with severe
initial motor impairment are in the greatest need of novel and efficacious rehabilitation interventions. Therefore,
our central hypothesis is that administration of progressive abduction loading therapy, shown to elicit sustained
improvements in individuals with severe chronic stroke, will augment conventional acute and subacute
rehabilitation through improved reaching function and attenuated development of loss of independent joint
control. To test this hypothesis, we will recruit individuals with severe initial motor impairment and administer
progressive abduction loading therapy as adjuvant to conventional in-patient and day-rehabilitation. A
comparison group of dosage-matched reaching practice without abduction loading will be utilized. Study
participants will be evaluated at admission, weekly until discharge, and then every other month until 1 year
following baseline. Between group comparisons will be made over the duration of the first year of recovery (Aim
1). Approximately half of the study participants will transition to day-rehabilitation following in-patient
rehabilitation and continue to receive the study interventions. The effect of extending progressive abduction
loading therapy into subacute recovery will be tested with the addition of a dichotomous variable of enrollment
in day-rehabilitation or not (Aim 2). Efficacy and dosage data will provide a go-no-go signal for the future
administration of a large-scale pivotal phase III clinical trial. Longitudinal data will determine if progressive
abduction loading therapy attenuates the development of loss of independent joint control.
项目摘要
上肢中风恢复慢性阶段的临床前康复研究表明
通过降低表达方式来改善严重损害的个体独立关节控制的能力
根据科学基于数据驱动
干预方法。二十年的定量运动系统研究基于
系统地针对该人群中的独立关节控制。主要的假设解释了中风 -
独立关节控制的相关损失是增加对对侧皮质肺导脊髓段的依赖性
受影响的手臂运动的产生。部分恢复独立关节控制
临床前研究从逻辑上扩展了这一假设,通过将改进的运动归因于优化的剩余使用
ipsiles性皮质脊髓束可能起源于缺血性半阴茎。残留的解剖回路
ipsilesipal corticolostinal束是唯一可用于生产独立关节控制的神经途径,
或用功能性的角度,向外伸出重力。对患有严重的个体的神经影像学研究
支持这一假设的慢性中风,它可以阐明优化使用半体的假设
皮质脊髓道可以在恢复早期,特别是神经可塑性的关键时期,在
严重初始运动障碍的人。中风实践指南得出的结论是,患有严重的人
最初的运动障碍最需要新颖有效的康复干预措施。所以,
我们的核心假设是,进行性外展负荷疗法的给药,证明是持续的
严重慢性中风的个体的改善,会增加常规急性和亚急性
通过改善达到功能的康复和衰减独立关节损失的发展
控制。为了检验这一假设,我们将招募严重初始运动障碍的人并进行管理
作为常规住院和日间治疗的辅助术进行了进行性外展疗法。一个
将利用剂量匹配的剂量匹配实践的比较组,而无需外展负荷。学习
参与者将在入场时进行评估,每周直到出院,然后每隔一个月直到1年
遵循基线。在小组比较之间将在恢复第一年的时间内进行(AIM
1)。大约一半的研究参与者将过渡到住院后的日间纠正
康复并继续接受研究干预措施。扩展渐进绑架的效果
通过添加二分法变量,将测试将疗法加载到亚急性恢复中
是否在日间理通中(AIM 2)。功效和剂量数据将为未来提供无关的信号
给予大规模关键阶段III临床试验。纵向数据将确定是否进行
外展负荷疗法减弱了独立关节控制丧失的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael D. Ellis其他文献
Michael D. Ellis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael D. Ellis', 18)}}的其他基金
Progressive Abduction Loading Therapy: A Phase IIb Stroke Rehabilitation Trial with Longitudinal Tracking
渐进性外展负荷疗法:纵向追踪的 IIb 期中风康复试验
- 批准号:
10219316 - 财政年份:2019
- 资助金额:
$ 48.38万 - 项目类别:
Progressive Abduction Loading Therapy: A Phase IIb Stroke Rehabilitation Trial with Longitudinal Tracking
渐进性外展负荷疗法:纵向追踪的 IIb 期中风康复试验
- 批准号:
10470718 - 财政年份:2019
- 资助金额:
$ 48.38万 - 项目类别:
Progressive Abduction Loading Therapy: A Phase IIb Stroke Rehabilitation Trial with Longitudinal Tracking
渐进性外展负荷疗法:纵向追踪的 IIb 期中风康复试验
- 批准号:
9814326 - 财政年份:2019
- 资助金额:
$ 48.38万 - 项目类别:
相似国自然基金
肿瘤微环境多层次调控的功能化纳米佐剂用于增强膀胱癌放疗疗效的机制研究
- 批准号:82303571
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
皮内接种抗原佐剂复合疫苗跨器官诱导呼吸道黏膜免疫反应
- 批准号:82341042
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
双重生物响应性自佐剂聚多肽载体构建高效mRNA癌症疫苗
- 批准号:52373299
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新型免疫调节复合佐剂的机制研究及在疫苗开发中的应用
- 批准号:82341039
- 批准年份:2023
- 资助金额:95 万元
- 项目类别:专项基金项目
相似海外基金
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
- 批准号:
10429480 - 财政年份:2022
- 资助金额:
$ 48.38万 - 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
- 批准号:
10621820 - 财政年份:2022
- 资助金额:
$ 48.38万 - 项目类别:
Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke
血液转录组学作为 CT 佐剂排除急性中风出血
- 批准号:
10611988 - 财政年份:2020
- 资助金额:
$ 48.38万 - 项目类别:
Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke
血液转录组学作为 CT 佐剂排除急性中风出血
- 批准号:
10396630 - 财政年份:2020
- 资助金额:
$ 48.38万 - 项目类别:
Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke
血液转录组学作为 CT 佐剂排除急性中风出血
- 批准号:
10210310 - 财政年份:2020
- 资助金额:
$ 48.38万 - 项目类别: